Scott Berg

Similarweb Analyst Initiates Coverage, Praises Firm For 'Rapidly Improving Profitability'
Docusign Reports Beat-And-Raise Quarter, But These Analysts Have Some Concerns
Workday Stock Soars As Analysts Call Q2 A 'Turning Point'
Docusign Reports Beat-And-Raise Quarter, But These Analysts Have Some Concerns
Workday Stock Soars As Analysts Call Q2 A 'Turning Point'
DocuSign Reports A 'Skinny Beat' With 'Street's Calibration To The New Cadence May Take A Quarter Or Two'
Does Workday Have 'Some Pockets Of Strength'? 11 Analysts Look At Q1 Results, Outlook

Scott Berg Recent News

Salesforce Delivers Upside 'Across The Board': 5 Analysts React To Strong Q2 Performance
Shares of Salesforce Inc (NYSE: CRM) spiked in early trading on Thursday, after the company reported better-than-expected quarterly results and issued strong guidance.
Workday Shines Through Industry 'Storm Clouds': What 6 Analysts Think Of Q2 Print
Shares of Workday Inc (NASDAQ: WDAY) rose in early trading on Friday, after the company reported its fiscal second-quarter results.
BILL Holdings' Q4 Results: 6 Analysts Respond To Macro Headwinds Impacting Revenue Projections
Shares of BILL Holdings Inc (NYSE: BILL) rose in early trading on Friday, amid big moves by Information Technology stocks.
Salesforce's AI Strategy Is 'Firming Up': 4 Analysts On Q1 Print, Outlook
Shares of Salesforce Inc (NYSE: CRM) tanked in early trading on Thursday, despite the company reporting upbeat revenues and earnings for its first quarter.
What These 4 DocuSign Analysts Have To Say About Q4 Print
Shares of DocuSign Inc (NASDAQ: DOCU) fell in the premarket on Friday, even after the company reported better-than-expected fourth-quarter earnings.
7 Salesforce Analysts On Q4 Earnings: 'Nearly Everything Investors Could Hope For'
Shares of Salesforce Inc (NYSE: CRM) were rallying Thursday morning after the company reported a fourth-quarter beat. Here's what the Street has to say. 
5 Salesforce Analysts Offer Their Takes On Q3 Print, Taylor's Departure As Co-CEO
Salesforce Inc (NYSE: CRM) recently reported its third-quarter results and that Bret Taylor will step down as co-CEO. Here's how analysts reacted.
DocuSign Shares Gain On 'Better-Than-Feared' Earnings Beat: 5 Analysts Chime In
Shares of DocuSign Inc. (NASDAQ: DOCU) jumped more than 17% in Friday’s pre-market after the company reported better-than-expected quarterly results and raised its full-year billings outlook. Here's what analysts had to say:
7 Coupa Software Analysts React To Q1 Earnings Beat: 'Lots Of Noise Around Billings'
Coupa Software Inc (NASDAQ: COUP) shares traded higher by 1.8% on Tuesday after the company reported strong earnings numbers and record subscription revenues in the first quarter.
9 Salesforce Analysts React To Q1 Earnings Beat: 'Next Quality Software GARP Stock'
Salesforce Inc (NYSE: CRM) shares jumped Wednesday morning after the company reported first-quarter earnings and raised its profit forecast.
Coupa Analysts Unanimously Think Shares Are Fairly Valued Following Post-Earnings Sell-off; 'Improvement Will Take Time'
Coupa Software Inc (NASDAQ: COUP) shares are tumbling on Tuesday after the business spend management software provider issued a below-consensus revenue forecast.
Salesforce Stock Falls After Q3 Earnings: Analysts React To Conservative Guidance, Mulesoft Headwinds
Salesforce.com, inc. (NYSE: CRM) shares fell Wednesday after the company missed expectations with its fourth-quarter guidance.
Five9 Shareholders Will Likely Reject Zoom Deal, Needham Says
Zoom Video Communications Inc’s (NASDAQ: ZM) current offer to acquire Five9 Inc (NASDAQ: FIVN) seems “fundamentally flawed,” according to Needham.
DocuSign Stock Jumps After Q2 Earnings: 4 Analysts React To eSignature Momentum, Agreement Cloud Traction
Docusign Inc (NASDAQ: DOCU) shares traded higher by 5.1% on Friday after the company reported a second-quarter earnings beat and raised its guidance.
Anaplan Stock Jumps After Q2 Earnings: 4 Analysts React To Return Of Digital Transformation Spending
Anaplan Inc (NYSE: PLAN) shares gained 11.2% on Wednesday after the company reported second-quarter earnings and revenue beats and raised its full-year guidance.
Bill.com Stock Jumps After Q4 Earnings: 4 Analysts React To Accelerating Organic Growth, Divvy Momentum
Bill.com Holdings Inc (NYSE: BILL) shares rallied Friday after the company reported better-than-expected fourth-quarter sales numbers.
Salesforce Stock Jumps After Q2 Earnings: 8 Analysts React To Big Deals And Impressive Growth
Salesforce.com, inc. (NYSE: CRM) traded higher by 4.6% on Thursday after the company reported impressive second-quarter earnings numbers and raised its full-year guidance.
5 Salesforce Analysts Break Down Q1 Beat: 'Executing On Improving Growth And Margins'
Shares of Salesforce.com, inc. (NASDAQ: CRM) jumped 5.43% on Friday after the company reported accelerating growth in the first quarter and issued impressive full-year guidance.
UiPath Provides 'Big Opportunity, But Big Multiple To Match,' Says Analyst Initiating Coverage
UiPath Inc (NYSE: PATH) shares are up more than 20% since the company priced its April IPO at $56.
3 DocuSign Stock Analysts On Q4 Results: Should Investors Buy The Dip?
Shares of DocuSign, Inc. (NASDAQ: DOCU) dipped Thursday afternoon after the eSignature solution company reported fourth-quarter results that disappointed some investors.
Why Needham Likes Cloud Stock Anaplan In 2021
Cloud-based software stocks have done well amid the work-from-home and study-from-home environment necessitated by the COVID-19 pandemic in 2020. Despite the pricier valuation of the category, an analyst at Needham picked one of the stocks as a recovery play in 2021.
6 Salesforce Analysts React To Slack Deal: 'Game-Changer Potential'
Shares of salesforce.com, inc. (NYSE: CRM) were trading lower Wednesday after the company reported earnings and revenue beats in the third quarter but fell short of expectations for its fourth-quarter guidance.
Wall Street Analysts See These 4 Stocks As Winners Moving Into December
The advancements with COVID-19 vaccines of Pfizer Inc. (NYSE: PFE), Moderna Inc. (NASDAQ: MRNA), and AstraZeneca Inc. (NASDAQ:

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved